Articles tagged with Chromosomal Abnormalities
New practice guidelines in Canada recommend prenatal screening for chromosomal abnormalities be offered to all pregnant women. The guidelines aim to balance reproductive autonomy with the potential legal liability of failing to screen, which could harm disabled children.
Current prenatal biochemical screening tests only detect half of chromosomal abnormalities, including trisomies and deletions. This limitation emphasizes the importance of counseling patients on the limitations of these tests to make informed decisions about invasive diagnostic testing.
Researchers found that embryos initially deemed abnormal can undergo chromosomal modifications, leading to a higher rate of mosaicism. This challenges the effectiveness of preimplantation genetic screening (PGS) for increasing pregnancy potential.
A massive international study identifies potential genetic links for autism, shedding light on the disorder's neurological basis. The research, involving over 1,400 families, suggests that certain genes increase the risk of developing autism, while environmental factors also play a role.
A study found that withdrawing full karyotyping from prenatal diagnosis for Down's syndrome could lead to undetected other chromosome abnormalities, resulting in preventable mental or physical handicaps. The researchers suggest using PCR plus karyotyping for more efficient detection of clinically significant chromosome abnormalities.
Researchers found that AML patients with abnormal chromosomes during remission are more likely to relapse and have a shorter survival. This suggests that routine testing for chromosomal abnormalities may be necessary to predict long-term outcomes in these patients.
A retrospective study of 249 children with ALL found that most chromosome abnormalities had little impact on prognosis, except for those involving the loss of chromosomes 7 and 9. In these cases, only 15% remained disease-free five years after treatment.
A study published in The Lancet suggests that prenatal genetic testing should be offered to all pregnant women, regardless of age or risk, as it is cost-effective. The researchers found that the benefits of early testing outweigh the costs, particularly for high-risk pregnancies.
Researchers identified chromosomal abnormalities in 5.9% of ALS patients, suggesting a previously unknown risk factor for the disease. The study highlights the need for systematic genetic analysis of patients with ALS and other neurodegenerative diseases.
A recent study by W. Allen Hogge, M.D., found that nearly 56% of miscarriages are caused by chromosomal abnormalities, with higher rates among women over 35. The study recommends regular karyotyping tests after the second loss and more advanced testing only when no genetic abnormality is found.
A 40% higher risk of chromosomal anomalies was found for residents living close to landfill sites compared to those further away. The study suggests that proximity to landfill sites is associated with an increased risk of congenital chromosomal abnormalities.
Researchers at University College London Medical School have made a major advance in assisted reproductive techniques with a new chromosome testing technique. The technique allows for the assessment of every single chromosome in virtually every cell of a test-tube embryo, potentially leading to improved IVF success rates.
The German-Japanese Consortium has successfully sequenced human chromosome 21, revealing 225 genes with implications for understanding trisomy 21 and other diseases. The findings also challenge previous estimates of the total number of human genes, suggesting a revised estimate of around 40,000.
Scientists analyzed chromosome 22 structure and found unstable areas with repetitive sequences where genes are prone to rearrangements. These low-copy repeats may cause the loss of important genes in chromosome 22q11 deletion syndrome, a common genetic disorder affecting hundreds of patients.
Researchers at Johns Hopkins Medicine verified Down syndrome in a genetically modified mouse model, finding identical skull and facial deformities as seen in humans. The study used sophisticated statistical techniques to match the mice' data with well-established characteristics of DS patients.
The study shows how chromosomes are distributed unevenly during cancer cell division, leading to genetic defects and abnormal growth. The researchers also discovered a breakage-fusion-bridge cycle that can amplify gene copies contributing to cancer growth.
Researchers at Children's Hospital of Philadelphia successfully sequenced nearly 700 genes on chromosome 22, a major breakthrough in genetic medicine. The completed sequence provides the order of 33 million DNA bases, laying the groundwork for further research into genetic diseases associated with this chromosome.
Scientists isolate UFD1 gene, linked to cardiac and facial anomalies in children with 22q11 deletion syndrome, a condition affecting one in 4,000 births. The study suggests that dysregulation of this gene leads to the development of heart and craniofacial structures.